Journal of the American Society of Nephrology (JASN) podcast

sGC Activator Avenciguat for CKD

0:00
21:55
Reculer de 15 secondes
Avancer de 15 secondes
Dr. Hiddo J.L. Heerspink discusses the findings from his study, "Effect of Avenciguat on Albuminuria in Patients with CKD: Two Randomized Placebo-Controlled Trials" with JASN Editor-in-Chief Rajnish Mehrotra.

D'autres épisodes de "Journal of the American Society of Nephrology (JASN)"